Company: INMB
Filing Date: 2025-08-07
Form Type: 10-Q
Source: 0001213900-25-073077
Chunk: 224

Company: Inmune Bio, Inc.
Filing Date: 2025-08-07
Form: 10-Q
Item: Part II, Item 6
Chunk 224
---
Item 6. Exhibits 

    No.
     
    Description 

    10.1
     
    Second Amended and Restated INmune Bio Inc. 2021 Stock Incentive Plan (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed with the SEC on June 10, 2025)  

    10.2
     
    Form of Securities Purchase Agreement, dated June 27, 2025 (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed with the SEC on June 30, 2025)

    10.3
     
    Form of Placement Agency Agreement, dated June 27, 2025 (incorporated by reference to Exhibit 10.2 to the Company’s Current Report on Form 8-K filed with the SEC on June 30, 2025)

    10.4
     
    Severance Agreement, dated August 4, 2025, between INmune Bio Inc. and Raymond J. Tesi†* 

    10.5
     
    Employment Agreement, dated December 16, 2021, between INmune Bio Inc. and Cory Ellspermann†*

    31.1
     
    Rule 13a-14(a)/ 15d-14(a) Certification of Principal Executive Officer*

    31.2
     
    Rule 13a-14(a)/ 15d-14(a) Certification of Chief Financial Officer*

    32.1
     
    Section 1350 Certification of Principal Executive Officer**

    32.2
     
    Section 1350 Certification of Chief Financial Officer**

    101.INS
     
    Inline XBRL Instance Document.

    101.SCH
     
    Inline XBRL Taxonomy Extension Schema Document.

    101.CAL
     
    Inline XBRL Taxonomy Extension Calculation Linkbase Document.

    101.DEF
     
    Inline XBRL Taxonomy Extension Definition Linkbase Document.

    101.LAB
     
    Inline XBRL Taxonomy Extension Label Linkbase Document.

    101.PRE
     
    Inline XBRL Taxonomy Extension Presentation Linkbase Document.

    104
     
    Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).

*